Goto Atsushi, Okamoto Takeshi, Ogawa Ryo, Hamabe Kouichi, Hashimoto Shinichi, Nishikawa Jun, Takami Taro
Department of Gastroenterology and Hepatology, Yamaguchi University Graduate School of Medicine, Ube, Japan.
Department of Gastroenterology and Hepatology, Yamaguchi Prefectural Grand Medical Center, Hofu, Japan.
Clin Endosc. 2022 Jul;55(4):520-524. doi: 10.5946/ce.2021.262. Epub 2022 Jul 28.
BACKGROUND/AIMS: Intralesional steroid injections have been administered as prophylaxis for stenosis after esophageal endoscopic submucosal dissection. However, this method carries a risk of potential complications such as perforation because a fine needle is used to directly puncture the postoperative ulcer. We devised a new method of steroid intralesional infusion using a spray tube and evaluated its efficacy and safety.
Intralesional steroid infusion using a spray tube was performed on 27 patients who underwent endoscopic submucosal dissection for superficial esophageal cancer with three-quarters or more of the lumen circumference resected. The presence or absence of stenosis, complications, and the number of endoscopic balloon dilations (EBDs) performed were evaluated after treatment.
Although stenosis was not observed in 22 of the 27 patients, five patients had stenosis and dysphagia requiring EBD. The stenosis in these five patients was relieved after four EBDs. No complications related to intralesional steroid infusion using the spray tube were observed.
Intralesional steroid infusion using a spray tube is a simple and safe technique that is adequately effective in preventing stenosis Clinical trial number (UMIN000037567).
背景/目的:内镜下食管黏膜下剥离术后,已采用病灶内注射类固醇预防狭窄。然而,由于使用细针直接穿刺术后溃疡,该方法存在穿孔等潜在并发症风险。我们设计了一种使用喷雾管进行类固醇病灶内输注的新方法,并评估其疗效和安全性。
对27例行内镜下黏膜下剥离术治疗浅表食管癌且切除管腔周长四分之三或更多的患者,采用喷雾管进行类固醇病灶内输注。治疗后评估狭窄情况、并发症以及内镜下球囊扩张(EBD)次数。
27例患者中22例未观察到狭窄,但有5例出现狭窄并伴有吞咽困难,需行EBD。这5例患者经4次EBD后狭窄缓解。未观察到与使用喷雾管进行类固醇病灶内输注相关的并发症。
使用喷雾管进行类固醇病灶内输注是一种简单、安全的技术,在预防狭窄方面效果良好。临床试验编号(UMIN000037567)。